Fulcrum Therapeutics's Earnings Outlook
Fulcrum Therapeutics's Earnings Outlook
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement.
納斯達克上的fulcrum therapeutics（納斯達克代碼：FULC）定於2024年11月13日（星期三）公佈最新季度業績。投資者在公佈前需要了解的內容如下。
Analysts estimate that Fulcrum Therapeutics will report an earnings per share (EPS) of $-0.41.
分析師估計fulcrum therapeutics將公佈每股收益（EPS）爲-0.41美元。
Investors in Fulcrum Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
fulcrum therapeutics的投資者急切期待公司的公告，希望獲得超出預期的消息，併爲下一個季度提供積極的指引。
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
值得新投資者注意的是，股票價格往往受未來預期的影響，而不僅僅是過去的業績。
Historical Earnings Performance
歷史業績表現
During the last quarter, the company reported an EPS beat by $0.88, leading to a 2.91% drop in the share price on the subsequent day.
在上個季度，該公司報告的每股收益超出0.88美元，導致股價在隨後一天下跌了2.91%。
To track all earnings releases for Fulcrum Therapeutics visit their earnings calendar on our site.
要跟蹤fulcrum therapeutics的所有業績發佈，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成，並由編輯審核。
譯文內容由第三人軟體翻譯。
